Vioguard has developed the first self-disinfecting computer keyboard specifically designed to help reduce the spread of preventable infections.

April 9, 2009 - PQRST Global Technologies displayed its VITUS telecardiology platform to share data, images and ECGs this week at HIMSS 20009 in Chicago.

April 9, 2009 -Physicians can dramatically reduce the radiation dose delivered to patients undergoing coronary CT angiography in a "triple rule-out" protocol by simply using tube current modulation, according to a study performed at Thomas Jefferson University Hospital in Philadelphia, PA.

April 9, 2009 - Epic showed its newly introduced cardiovascular module for its electronic medical record (EMR) this week at HIMSS 2009 in Chicago.

April 9, 2009 - A fundamental issue facing healthcare worldwide is tying fragmented information and data silos together to increase intelligence, and Initiate Interoperable Health solutions showcased its vendor-neutral “middleware” to bridge disparate data during HIMSS 2009 in Chicago this week.

April 9, 2009 – Vital Images recently announced the results of an independent survey of nearly 2,400 U.S. hospitals with more than 100 beds, which showed Vital Images continues to be the market share leader among 3D imaging vendors.

April 9, 2009 - Vital Images Inc. has achieved certification for Excellence in Service Operations by the Service & Support Professionals Association (SSPA), a certification benchmarked against industry best practices in a number of areas, including support operations, customer satisfaction, service sales and marketing, product serviceability, technology infrastructure and human resource systems.

April 9, 2009 - Sage said its new Intergy Electronic Health Record (EHR) Version 5.5 allows for better medical device integration and auto-populates fields with information from many common cardiology devices. The company displayed the newest version of its EHR at HIMSS 2009 in Chicago this week.

April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ischemic events in the one year following percutaneous coronary intervention (PCI).

April 9, 2009 - A successful randomized, double-blinded, placebo-controlled phase 2 clinical trial using an intramyocardial injection of a patient’s own CD34 stem cells as treatment for refractory angina has been completed, and included 22 centers across the U.S.

Subscribe Now